Eyenuk, Inc.

Eyenuk and Alta Tecnología Médica S.A. Partner for Distribution of the EyeArt System in Chile. #Eyenuk today announced its partnership with Alta Tecnología Médica S.A. (ATM), a leading provider of advanced medical technologies in Chile for the distribution of EyeArt artificial intelligence (AI) system for autonomous #diabeticretinopathy detection. Chile has the second highest incidence of #diabetes in South America with nearly 2 million people with diabetes. #EyeArt #AIEyeS...creening #ChileDigital #ArtificialIntelligence https://www.eyenuk.com//eyenuk-alta-tecnologia-medica-par/ See more

Eyenuk Commentary on Diabetes Care Publication (Aaron Y. Lee et al., Diabetes Care 2021) January 13, 2021 The Eyenuk team has been encouraged to witness the worldwide interest and inquires related to the research paper, Multicenter, Head-to-Head, Real-World Validation Study of Seven Automated Artificial Intelligence Diabetic Retinopathy Screening Systems, published online by Diabetes Care, January 4, 2021. Eyenuk is pleased to confirm that our EyeArt AI technology was the... best performing algorithm in this study (Algorithm G)! We also want to point out that like all retrospective analyses, this study has certain limitations that make it difficult to draw conclusions regarding each algorithm’s true sensitivity and specificity. Click below to download a detailed analysis by Eyenuk: https://cdn.eyenuk.com//Eyenuk-Commentary-on-VA-Head-to-He @ADA_Journals @amdiabetesassn @UniversityofWA #veteranaffairs #diabetescare #diabeticretinopathy #artificialintelligence #EyeArt https://www.eyenuk.com//eyenuk-commentary-on-aaron-lee-et/

The Diabetes Care Journal just published a landmark study with patient data from the United States Department of Veterans Affairs (VA). In this multicenter, noninterventional study on more than 300,000 retinal images from over 20,000 veterans at the Puget Sound and Atlanta VA Healthcare Systems, Aaron Y. Lee MD MSCI and his VA colleagues performed an independent, head-to-head validation to compare automated artificial intelligence (AI) diabetic retinopathy (DR) screening systems. #EyeArt #Eyenuk #diabetescare #diabeticretinopathy #artificialintelligence #veteranaffairs https://www.eyenuk.com//us-veterans-affairs-publishes-hea/

Happy Holidays from The #Eyenuk Team!

#Eyenuk is pleased to announce that its EyeArt AI System for autonomous #diabeticretinopathy detection has been granted regulatory approval by #INVIMA, the Colombian governmental regulatory agency that oversees healthcare. Colombia has approximately 3 million people with diabetes and is one of the largest Latin American markets for diabetic eye testing. #EyeArt #AIEyeScreening #ArtificialIntelligence #LATAM... https://www.eyenuk.com//eyenuk-receives-approval-in-colom/ See more

Happy #Thanksgiving from The #Eyenuk Team!

World Health Organization (WHO) Features #Eyenuk AI Initiative Supporting National Diabetic Retinopathy Screening in Armenia. https://www.eyenuk.com//world-health-org-who-features-eye/ #EyeArt #AIEyeScreening #ArtificialIntelligence #DiabeticRetinopathy

Join our expert panel at 8a PST on 11/5 for a webinar to learn about our #EyeArt system and how Autonomous #AI is transforming the early detection of #diabeticretinopathy. Register today: http://bit.ly/EyeArtWebinar

Over 146m people are living with #diabeticretinopathy. On #WorldSightDay, we celebrate our commitment to delivering the only FDA-cleared Autonomous AI solution for detection of vision-threatening Diabetic Retinopathy. Learn more at Eyenuk.com. #HopeInSight #WSD2020

Join us in celebrating #WorldSightDay. A billion people have a vision impairment that could have been prevented. International Agency for the Prevention of Blindness (IAPB) #HopeInSight #WSD2020

The Temple University Health System recently expanded its point-of-care eye screening program using #Eyenuk AI technologies to twelve general practice and internal medicine clinics throughout the city of Philadelphia. #Eyenuk #EyeArt #ArtificialIntelligence #AIEyeScreening https://www.eyenuk.com//leading-us-health-system-expands-/

Did you know #worlddiabetesday is held annually on November 14 to mark the birth of Sir Frederick Banting, a Canadian medical scientist who co-discovered insulin?

Today Eyenuk, Inc. is honored to be highlighted by World Diabetes Foundation for phenomenal real-world clinical results delivered with Armenian EyeCare Project 16,000 people were screened by #EyeArt AI, 8,500 were diagnosed with #diabeticretinopathy or diabetic macular edema, and 1,229 people received timely treatment. #Eyenuk #EyeArt #AIEyeScreening #artificialintelligence https://www.worlddiabetesfoundation.org//armenian-diabetes

#ArtificialIntelligence Brings DR Screening Beyond Eye-Care Practices. A new device achieves autonomous detection of vision-threatening #diabeticretinopathy . Retinal Physician #Eyenuk #EyeArt #AIEyeScreening #DiabeticRetinopathy https://www.retinalphysician.com//new-product-applications

Eyenuk is honored to be featured as the latest Small Business Success Story by the National Institute of Health (NIH). Eyenuk’s innovations have been supported by significant grant funding from #NIH covering #artificialintelligence for #diabeticretinopathy, #AMD, #glaucoma and #alzheimers. https://sbir.nih.gov/stories/eyenuk

Check out Eyewire News video highlighting the historical FDA clearance of the #EyeArt AI System for autonomous detection of both More than Mild and vision-threatening diabetic retinopathy. #Eyenuk #AIEyeScreening #artificialintelligence #deeplearning #diabetes #diabeticretinopathy #ophthalmology #optometry #FDA

FDA clears EyeArt Autonomous AI System for diabetic retinopathy screening! Great news for 30+ million Americans living with diabetes, especially the ~1 million who have vision-threatening DR. #Eyenuk #EyeArt #FDACleared #AIEyeScreening #DeepLearning #ArtificialIntelligence #DiabeticRetinopathy U.S. Food and Drug Administration https://www.businesswire.com//Eyenuk-Announces-FDA-Clearan

Exciting to see EyeArt’s exceptional results just published based on UK-wide independent pivotal study, with large sample size of more than 120,000 images of real-world patients. #Eyenuk #EyeArt #artificialintelligence #deeplearning #AIEyeScreening #diabeticretinopathy Gloucestershire Hospitals NHS Foundation Trust Guy's and St Thomas' NHS Foundation Trust Moorfields Eye Hospital Homerton University Hospital St George's University Hospitals NHS Foundation Trust ... BMJ https://medicalxpress.com//2020-07-artificial-intelligence

Devlyn Optical, affiliated with more than 1,000 #opticalshop locations in Mexico, U.S., and other countries, is teaming up with Eyenuk, Inc. to pilot in-store diabetic retinopathy screening enabled by AI and telemedicine. #optometry #optician #losangeles #telehealth #eyecare #diabeticretinopathy #artificialintelligence https://www.businesswire.com//Multinational-Optical-Retail

@WebMD digital publication Artificial intelligence and You highlights #Eyenuk innovations under the section AI Already Transforms Medicine. A screening sys...tem developed by a California-based company called Eyenuk Inc. can detect diabetic retinopathy, a leading cause of preventable blindness worldwide. Instead of waiting months for an appointment with a specialist, the EyeArt AI Screening System can deliver a diagnosis in less than a minute, wrote WebMD. #ArtificialIntelligence #MachineLearning #DeepLearning #BigData #EyeArt #ophthalmology #telehealth #optometry #diabeticretinopathy #eyescreening #diabetes Follow the link to the full digital publication (PDF): https://img.webmd.com//digita/JanFeb20_AI_DigitalIssue.pdf

#EyeArt achieves 100% sensitivity in detecting vision-threatening #diabeticretinopathy, according to latest research published on BMJ Ophthalmology (@BJOphthalmology). Over 425 million people around the world have #diabetes, and almost 10% of them have vision-threatening diabetic retinopathy. With authors from @Moorfields, @NHSHomerton and @UCL, the publication found EyeArt #artificialintelligence #eyescreening could reduce the need to grade normal patients’ eye images by two...-thirds within the English National Diabetic Eye Screening Program #NDESP). #EyeArt processed images acquired by #CenterVue #EIDON platform with state-of-the-art wide-field true-color confocal scanning technology, as well as images acquired by other types of #funduscamera. #NHS #ophthalmology #telehealth https://www.businesswire.com/news/home/20200519005330/en/

Eyenuk Invited to Present at the American Optometric Association (AOA) TeleHealth Conference as AOA Assembles Industry Leaders to Set Future Guidance for Telehealth Amid the COVID-19 public health emergency, doctors are considering the use of telehealth-based care, as patients practice social distancing to avoid community spread. Prior to the current crisis, though, the AOA recognized the increasing role of telehealth-based care. At the AOA Telehealth Conference, Eyenuk Chief... Commercial Officer Frank Cheng shared Eyenuk’s perspective on how telemedicine and artificial intelligence can improve access, quality and efficiency of eye care during and post the COVID-19 pandemic. Industry leaders representing other companies also presented at the meeting. These companies included Alcon, CooperVision, Essilor, EyecareLive, Johnson & Johnson Vision, Versant Health and VSP. #Eyenuk #EyeScreen #EyeArt #AIEyeAcreening #DiabeticRetinopathy https://www.eyenuk.com//eyenuk-invited-to-present-at-ameri